|
| 8-Bromo-3-methyl-xanthine Basic information |
Product Name: | 8-Bromo-3-methyl-xanthine | Synonyms: | 8-Bromo-3-methyl-xanthine;8-Bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione;8-bromo-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione;8-Bromo-3-methyl-7H-purine-2,6-dione;8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione;8-broMo-3-Methyl-1H-purine-2,6(3H,7H);1H-purine-2,6-dione, 8-broMo-3,7-dihydro-3-Methyl-;3-Methyl-8-broMoxanthine | CAS: | 93703-24-3 | MF: | C6H5BrN4O2 | MW: | 245.03 | EINECS: | 819-117-0 | Product Categories: | bc0001;93703-24-3 | Mol File: | 93703-24-3.mol | |
| 8-Bromo-3-methyl-xanthine Chemical Properties |
Melting point | 300°C(lit.) | density | 1.974 | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | solubility | DMF (Slightly), DMSO (Slightly) | form | powder to crystal | pka | 7.65±0.20(Predicted) | color | White to Almost white |
| 8-Bromo-3-methyl-xanthine Usage And Synthesis |
Chemical Properties | Light yellow solid | Uses | 8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione, is a substituted derivative of Xanthine (X499950), found in animal organs, yeast, potatoes, coffee beans, tea. It can also be used for the synthesis of Linagliptin (L465900), which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
| 8-Bromo-3-methyl-xanthine Preparation Products And Raw materials |
|